Walleye Capital’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
Other funds holding URGN
KCM
ACA
OM
Walleye Capital's URGN Position: Q3 2026 in Review
Walleye Capital opened a new position in UroGen Pharma (URGN) in Q3 2026: 348,116 shares worth $14.1M. The stake represents 0.01% of the portfolio and ranks #993 among its holdings. This is a return to the name: Walleye Capital previously reported a position in URGN as recently as Q3 2025.
Walleye Capital first reported a position in URGN in Q4 2023 and has held it in 5 quarters since. 215 funds tracked by Wall St. Rank hold URGN as of Q3 2026.
- Walleye Capital held 348,116 shares of UroGen Pharma worth $14.1M as of Q3 2026.
- UroGen Pharma was a new Walleye Capital position in Q3 2026.
- UroGen Pharma made up 0.01% of Walleye Capital's portfolio in Q3 2026, its #993 holding.
- Walleye Capital first reported a position in UroGen Pharma in Q4 2023 and has held it in 5 quarters since.
- 215 funds tracked by Wall St. Rank held UroGen Pharma as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.